Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo

NCT00851344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG: GSK835726 (10mg)
DRUG: GSK835726 (50mg)
DRUG: GSK835726 (100mg)
DRUG: Cetirizine (10mg)
OTHER: Placebo

Sponsor

GlaxoSmithKline